Notícias

SARS-CoV-2 messenger RNA vaccination in healthy individuals generates immune protection against COVID-19. However, little is known about SARS-CoV-2 mRNA vaccine-induced...

The prioritization of U.S. health care personnel for early receipt of messenger RNA (mRNA) vaccines against severe acute respiratory syndrome...

The clinical impact of different prophylactic anticoagulation regimens among hospitalized patients with coronavirus disease 2019 (COVID-19) remains unclear. We pooled...

COVID-19 is associated with a wide range of clinical manifestations, including autoimmune features and autoantibody production. Here we develop three...

Resveratrol is a polyphenol that has been well studied and has demonstrated anti-viral and anti-inflammatory properties that might mitigate the...

Primeira edição do Science Talks EMS discute futuro do setor de saúde no Brasil no
pós-pandemia e destaca o...

Oxiteno é reconhecida no TOP 5 de indústrias químicas do ranking Open Corps 2021.
A companhia está entre as...

Eurofarma lança suplemento alimentar com combinação inédita de colágenos para a saúde das articulações. Fortice® é uma suplementação para a...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of the coronavirus disease 2019 (COVID-19), has caused more than...

Our understanding of the severe acute respiratory syndrome coronavirus 2 has evolved since the first reported cases in December 2019,...

Reverse vaccinology is an evolving approach for improving vaccine effectiveness and minimizing adverse responses by limiting immunizations to critical epitopes....

Coronavirus disease 2019 (Covid-19), caused by novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), has come to the fore in Wuhan,...